ReleaseWire Connect

Clinical operations is one part of the global economy that has faced a great deal of disruption as a result of COVID-19. In order to adapt to the new reality of a pandemic, trials and supply chains have been forced to swiftly evolve. Some of the factors that have had a big role to play include the reluctance of patients to attend clinical trials while the threat of coronavirus infection remained high - which has jeopardized the data that has been received from clinical trials - as well as the import and export controls that have impacted on the transport of medical supplies.

Clinical jobs offer a wealth of different career options today, often at the forefront of cutting-edge innovation in healthcare and life sciences. Technology is creating many new career paths, providing new ways to tackle old issues that have held back progress for years. Appia Bio is one business capitalizing on this, for example, as it has entered into the cell therapy field with a promising scalable technology platform that it will use in its development of engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients.

Astrazeneca is a name that has become synonymous with the COVID-19 vaccine roll out over the past year but that's not the only way the British pharma company is contributing to progress. A new collaboration has been announced between Astrazeneca and the Cambridge-based biotech business Alchemab, which it is hoped will accelerate the research around prostate cancer.

The number of COVID-19 cases in India has been shocking for those involved in healthcare with the country rapidly overtaking its first wave peak in 2020. Since April, India has been recording more than 300,000 cases of COVID-19 every day and the health infrastructure in place in a number of Indian cities has already collapsed under the weight of these shocking numbers.

The COVID-19 vaccination programs have dominated the news headlines in recent months, especially in the context of countries where there is less structured healthcare provision and access to treatment is less than easy. While much of the western world works towards getting entire populations vaccinated, countries such as India are seeing infection rates spiraling out of control. However, the new Biden-Harris administration has been one of the first to recognize that steps need to be taken to ensure much more equal access to vaccines.

Clinical jobs have been at the heart of the global response to the COVID-19 pandemic, enabling governments to mobilize vaccine programs and care strategies that have helped to keep infection rates under control.

Clinical jobs span a broad spectrum of roles, from those "at the bench" to clinical operations careers that involve overseeing the research process and ensuring that protocols are being adhered to. In the year of COVID-19, the importance of the clinical trial has been much more broadly appreciated as many more people take an interest in how the process works and what's involved. In the US there have been critical trials that have underpinned the efficacy of various vaccines, including the AstraZeneca US Phase III trial, called D8110C00001.

There has never been a more exciting time to develop your career in the pharmaceutical industry. Pharma recruiters are on the lookout for diligent professionals who can be pioneers in the industry by providing all-encompassing expertise and knowledge. The Pharmaceutical Excipients Market is set to grow exponentially, with a projected CAGR of 5.8% by 2026, reaching USD 10.6 billion. The rising pharmaceuticals market, advancement in functional excipients, and the growing genetics market all add to the overall growth of the sector, which, in turn, has generated mass job openings for pharma professionals in the United States and beyond.

According to the FDA, a biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product. Biosimilars represent the fastest-growing class of therapeutic products in the United States. Biosimilars allow consumers to save money on health care without sacrificing treatment quality. As a product, they are incredibly important as they have the potential to offer consumer competition and increase patient access to essential medicines. With this in mind, it's not surprising that R&D professionals are in high demand throughout the USA to further sectors such as biosimilars.

Within the pharmaceutical industry, the US is incredibly well established, meaning that doors are often opened when it comes to trialling, producing and financing drugs and medicines that other countries have a shortage in capacity and facilities to successfully manage. This in turn, provides exciting opportunities for those looking to develop and advance their roles across a number of research and development sectors, all the while proving that the US is still one of the best places in the world to pursue a career in research and development.